Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma

lymphoma, b-cell, primary cbcl including (who/eortc classification 2005), primary cutaneous marginal zone b-cell lymphoma, primary cutaneous follicle center b-cell lymphoma, primary cutaneous diffuse large b-cell other than leg type, histologically consistent with primary cbcl, relapse or active disease, interventional, phase2